share_log

CN.ORTH: Clinical Hold Lifted in Time for 3Q:22 Results

Benzinga Real-time News ·  Dec 27, 2021 12:36

By John Vandermosten, CFA

CNSX:ORTH.CN | OTC:ORTIF

READ THE FULL ORTH.CN RESEARCH REPORT

Clinical Hold Letter Lifted

Following the April 2021 Investigational New Drug (IND) submission for Ortho-R, Ortho Regenerative Technologies Inc. (CSE:ORTH) (OTC:ORTIF) notified the public on December 13ththat the FDA had lifted its Clinical Hold on the application. Two months after its IND submission, Ortho announced that a clinical hold had been placed on the trial launch pending the collection of additional chemistry, manufacturing and control (CMC) related data and characterization of the chitosan product. On July 20th, Ortho announced that it...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment